Inhibition of NLRP3 inflammasome activation by A20 through modulation of NEK7
Proceedings of the National Academy of Sciences · 18.06.2024 · 121 (25)
DOI: 10.1073/pnas.2316551121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 12.06.2024. Verfasst von Jiayun Yu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiotherapy, Cancer Center, State Key Laboratory of Biotherapy, West China Hospital, National Clinical Research Center for Geriatrics,…. Hauptthemen laut MEDLINE: NIMA-Related Kinases, NLR Family, Pyrin Domain-Containing 3 Protein, Inflammasomes, Ubiquitination. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Foundation for Innovative Research Groups of the National Natural Science Foundation of China.
Abstract (Originalsprache)
The NLRP3 inflammasome, a pivotal component of innate immunity, has been implicated in various inflammatory disorders. The ubiquitin-editing enzyme A20 is well known to regulate inflammation and maintain homeostasis. However, the precise molecular mechanisms by which A20 modulates the NLRP3 inflammasome remain poorly understood. Here, our study revealed that macrophages deficient in A20 exhibit increased protein abundance and elevated mRNA level of NIMA-related kinase 7 (NEK7). Importantly, A20 directly binds with NEK7, mediating its K48-linked ubiquitination, thereby targeting NEK7 for proteasomal degradation. Our results demonstrate that A20 enhances the ubiquitination of NEK7 at K189 and K293 ubiquitinated sites, with K189 playing a crucial role in the binding of NEK7 to A20, albeit not significantly influencing the interaction between NEK7 and NLRP3. Furthermore, A20 disrupts the association of NEK7 with the NLRP3 complex, potentially through the OTU domain and/or synergistic effect of ZnF4 and ZnF7 motifs. Significantly, NEK7 deletion markedly attenuates the activation of the NLRP3 inflammasome in A20-deficient conditions, both in vitro and in vivo. This study uncovers a mechanism by which A20 inhibits the NLRP3 inflammasome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiotherapy, Cancer Center, State Key Laboratory of Biotherapy, West China Hospital, National Clinical Research Center for Geriatrics, Sichuan University, Chengdu 610041, China.
- State Key Laboratory of Oral Diseases and National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China.
- Department of Biotherapy, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China.
- Laboratory of Aging Research and Cancer Drug Target, State Key Laboratory of Biotherapy, West China Hospital, National Clinical Research Center for Geriatrics, Sichuan University, Chengdu 610041, China.
ORCID-Profile: Yongyao Wu, Bin Shao
Förderung
- Foundation for Innovative Research Groups of the National Natural Science Foundation of China
Zitieren
APA
Yu, J., Li, H., Wu, Y., Luo, M., Chen, S., Shen, G., Wei, X., & Shao, B. (2024). Inhibition of NLRP3 inflammasome activation by A20 through modulation of NEK7. Proceedings of the National Academy of Sciences, 121(25). https://doi.org/10.1073/pnas.2316551121
Vancouver
Yu J, Li H, Wu Y, Luo M, Chen S, Shen G, et al. Inhibition of NLRP3 inflammasome activation by A20 through modulation of NEK7. Proceedings of the National Academy of Sciences. 2024;121(25). doi:10.1073/pnas.2316551121
BibTeX
@article{Yu2024,
author = {Yu, Jiayun and Li, Hanwen and Wu, Yongyao and Luo, Min and Chen, Siyuan and Shen, Guobo and Wei, Xiawei and Shao, Bin},
title = {Inhibition of NLRP3 inflammasome activation by A20 through modulation of NEK7},
journal = {Proceedings of the National Academy of Sciences},
year = {2024},
volume = {121},
number = {25},
doi = {10.1073/pnas.2316551121}
}
EUVIMED